Sacituzumab Govitecan Significantly Prolongs Overall Survival in Patients With HR+/HER2- Metastatic Breast Cancer
Sacituzumab govitecan may represent a promising option for patients with endocrine resistant, hormone receptor–positive/HER2-negative metastatic breast cancer, according to updated findings from the phase 3 TROPiCs-02 study.
Black Patients With Metastatic Breast Cancer Experience More Hesitancy With Clinical Trial Enrollment
Although 83% of Black patients with metastatic breast cancer expressed interest in clinical trials, only 40% reported having a conversation about enrollment with their health care provider, highlighting one of many potential barriers to achieving clinical trial diversity.
Study Seeks to Identify Connection Between Cognitive function and Anxiety In Patients Receiving Chemotherapy
Unrelieved stress may contribute to cancer-related cognitive impairment and anxiety in patients undergoing chemotherapy.
Following ADT, Older Patients With Prostate Cancer Are at an Increased Risk of Cardiac Complications
Older men who have received androgen-deprivation therapy are an increased risk of heart issues, however, the root of the risk is still not well understood.
Cancer Survivors Struggling With Insomnia May Benefit from Cognitive Therapy
Cognitive therapies were found to be effective for helping cancer survivors with insomnia, but more research is needed for patients actively receiving treatment.
Cabozantinib Validated as Safe Post-Immunotherapy Option for Patients with mRCC
Cabozantinib is determined to be a safe treatment option for patients with metastatic renal cell carcinoma whose disease failed to respond to prior immunotherapy combinations.
High BMI in Localized Prostate Cancer Associated With Decreased Likelihood of Undergoing Surgery
Researchers identified a linear decrease in the likelihood of surgery once patients with localized prostate cancer reached a BMI of 33 or greater.
Rates of Upgrading, Adverse Pathology Similar in Hispanic and White Non-Hispanic Men With Prostate Cancer
Hispanics are the largest ethnic minority and one of the most rapidly growing populations in the United States. Prostate cancer represents the highest incident non-cutaneous malignancy in this population.
Yoga Encourages Antitumor Response, Boosts Quality of Life in Patients with Prostate Cancer
Yoga has a positive impact on the vagus nerve, which influences how people think, remember, and feel, and therefore can improve the mental well-being of patients with prostate cancer.
Retevmo Shows Improvement for Previously Treated Patients With Non-Small Cell Lung Cancer
Previously treated patients with non-small cell lung cancer tended to have better responses with Retevmo than they did with prior treatments.
Pralsetinib Is Tolerable, Durable in RET Fusion+ NSCLC
Pralsetinib elicited promising responses and tolerability in patients with RET fusion-positive non-small cell lung cancer (NSCLC), including those who were not eligible for platinum-based therapy.
COVID-19 Pandemic Shows ‘Silver Lining’ of Virtual Visits for Veterans Who Have Survived Cancer
Due to the COVID-19 pandemic, many patients’ and survivors’ care has changed, but one nurse and her team sought to make this population more comfortable and safe during these times with virtual visits.
Older Cancer Survivors Struggle to Cope During the COVID-19 Pandemic
Survivors of cancer go through coping during the first year after treatment and require specific resources. But these were limited due to the pandemic resulting in survivors self-coping with known mechanisms.
Improving Outcomes for Patients Experiencing Financial Toxicity
Financial toxicity has been linked to increased mortality rates, but can be improved with financial intervention for patients.
Immune Engager Therapies Improve Responses, PFS in RRMM After CAR T-Cell Therapy
Liso-Cel Elicits Rapid, Durable Responses in Relapsed/Refractory CLL/SLL
Adding Azoles May Not Impact Efficacy of Ruxolitinib in Acute GVHD Treatment
Ruxolitinib Plus Belumosudil Confers a 55% Response Rate in GVHD
2 Commerce Drive Cranbury, NJ 08512